Skip to main content
OpenTrials

Clinical trial condition

Chronic Urticaria

Explore clinical trials studying Chronic Urticaria. Study availability and eligibility vary by location and protocol.

139 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Chronic Urticaria trial results

Active, Not Recruiting

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT06445023

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Cahaba Dermatology Skin Health Center Birmingham, Alabama, United States
  • First OC Dermatology - Fountain Valley Fountain Valley, California, United States
  • 310 Clinical Research Inglewood, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 235 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

NCT06455202

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research - Cullman Cullman, Alabama, United States
  • Research Solutions of Arizona PC Litchfield Park, Arizona, United States
  • Medical Research of Arizona a division of Allergy, Asthma, & Immunology, Assoc. Ltd. Scottsdale, Arizona, United States
  • Center for Dermatology & Plastic Surgery Scottsdale, Arizona, United States
View all 245 locations
View Trial Details
Active, Not Recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details
Active, Not Recruiting

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

NCT05513001

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Cahaba Derm and skin hlth ctr 27 Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Acuro Research Inc Little Rock, Arkansas, United States
View all 208 locations
View Trial Details
Active, Not Recruiting

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +13 more
Locations
  • Investigative Site 118 Birmingham, Alabama, United States
  • Investigative Site 108 Little Rock, Arkansas, United States
  • Investigative Site 105 San Diego, California, United States
  • Investigative Site 116 Tampa, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)

NCT06162728

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +13 more
Locations
  • Site 118 Birmingham, Alabama, United States
  • Site 108 Little Rock, Arkansas, United States
  • Site 105 San Diego, California, United States
  • Site 113 Miami, Florida, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany

NCT06991608

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Novartis Investigative Site Lingen, Lower Saxony, Germany
  • Novartis Investigative Site Koblenz, Rhineland-Palatinate, Germany
  • Novartis Investigative Site Leipzig, Saxony, Germany
View all 20 locations
View Trial Details

Related conditions